Schedule at a Glance

Icon Legend

Presentation Icons

Ticketed Event

Norman J. Siegel New Member Outstanding Science Award

John Howland Award

Mary Ellen Avery Award

SPR Thomas A. Hazinski Distinguished Service Award

SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research

PROSPER Diversity Award

ASPN Founders’ Award

David G. Nichols Health Equity Award

ASPN Mid-Career Award

Awarded Part 4 Maintenance of Certification (MOC) Credit

Poster Icons

Awarded Part 4 Maintenance of Certification (MOC) Credit

Neonatal General 12: Prenatal Exposures

Type here to filter the list

Neonatal General 12: Prenatal Exposures

Favorite
426 - Evaluating Effects of Prenatal THC and Tobacco Exposure on Neonatal Lung Mechanics

Favorite
435 - Placental size and neonatal opioid withdrawal syndrome

Favorite
436 - Correlation between maternal dose of medication for opioid use disorder and drug levels in maternal urine and infant cord toxicology analysis

Favorite
437 - The impact of the implementation of Eat, Sleep, Console for the management of infants with Neonatal Opioid Withdrawal Syndrome on the morphine dose and length of stay

Favorite
438 - Frequency of Nasogastric Feeding Among Newborns with Opioid Withdrawal Syndrome Managed with the Modified Finnigan (MF) or Eat, Sleep, Console (ESC) Protocols

Favorite
439 - Comparison of Umbilical Cord and Meconium Toxicology Testing

Favorite
440 - Comparing Developmental and Growth Trajectories in Infants with and without Pharmacotherapy for Neonatal Opioid Withdrawal Syndrome: A Retrospective Cohort Study

Favorite
441 - Ethanol causes dose dependent alterations of BK distribution in Lipid Rafts of the Nucleus tractus solitarius of rat pups

Favorite
442 - In utero xylazine exposure is associated with feeding difficulties in infants with Neonatal Opioid Withdrawal Syndrome

Favorite
443 - Postnatal Head Ultrasound Findings in Preterm Infants Exposed Prenatally to Marijuana

Favorite
444 - QTc Comparison Between Neonates with Neonatal Opioid Withdrawal Syndrome and Healthy Non-Opioid Exposed Neonates

Favorite
427 - Developing a Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Further Characterize Impact on Neurodevelopmental Outcomes

Favorite
445 - Postnatal Morbidity in Neonates with Prenatal Exposure to Xylazine: A Case Series

Favorite
428 - Bowen Therapy for Nonpharmacologic Care of Patients with Neonatal Abstinence Syndrome

Favorite
429 - Neonatal abstinence syndrome, complications beyond withdrawal symptoms

Favorite
430 - Change in maternal e-cigarette use during pregnancy and preterm birth

Favorite
431 - Mothers with Concurrent Cocaine and Opioid Use and Neonatal Outcomes

Favorite
432 - Maternal dosage and urine/cord drug levels of medication for opioid use disorder as predictors of pharmacologic treatment for neonatal opioid withdrawal syndrome

Favorite
433 - Concordance of test results between maternal drug screen and urine versus cord tissue drug screens in newborns

Favorite
434 - Nasogastric and orogastric tube feeding among infants with intrauterine opioid exposure

Favorite